Hahn CG, Banerjee A, Macdonald ML, Cho DS, Kamins J, Nie Z, Borgmann-Winter KE, Grosser T, Pizarro A, Ciccimaro E, Arnold SE, Wang HY, Blair IA. The post-synaptic density of human postmortem brain tissues: an experimental study paradigm for neuropsychiatric illnesses. PLoS One. 2009;4(4):e5251. Epub 2009 Apr 16. PMID: 19370153

pdf

Marzoll A, Nagy N, Wördehoff L, Fries S, Lindner V, Grosser T, Fischer JW. Cyclooxygenase Inhibitors Repress Vascular Hyaluronan-Synthesis in Murine Atherosclerosis and Neointimal Thickening. J Cell Mol Med. 2009 Mar 17. [Epub ahead of print] PMID: 19320776 (IF: 5.114)

pdf

Stampfuss JJ, Censarek P, Fischer JW, Kaber G, Rauch BH, Freidel K, Fischer U, Schulze-Osthoff K, Grosser T, Grandoch M, Schrör K, Weber AA.Complete downmodulation of P-selectin glycoprotein ligand in monocytes undergoing apoptosis. Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):1375-8. (IF: 7.221; SJR: 1,270) PMID: 18451333

pdf

Lucitt MB, Price TS, Pizarro A, Wu W, Yocum AK, Seiler C, Pack MA, Blair IA, FitzGerald GA, Grosser T. Analysis of the zebrafish proteome during embryonic development. Molecular & Cellular Proteomics 7(5):981-94 (2008). (IF: 9.620; SJR: 2.170). MCP’s May issue Cover Figure (download)

pdf

Song WL, Wang M, Ricciotti E, Fries S, Yu Y, Grosser T, Reilly M, Lawson JA, FitzGerald GA. Tetranor PGDM: An abundant urinary metabolite reflects biosynthesis of PGD₂ in mice and humans. J Biol Chem 283(2):1179-88. (2008) (IF: 5.808; SJR: 1.896).

pdf

Censarek P, Steger G, Paolini C, Hohlfeld T, Grosser T, Zimmermann N, Fleckenstein D, Schror K, Weber AA. Alternative splicing of platelet cyclooxygenase-2 mRNA in patients after coronary artery bypass grafting. Thrombosis and Haemostasis 98(6):1309-15 (2007). (IF: 2.803; SJR: 0.515).

pdf

North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM, Weber G,  Jang IH, Grosser T, FitzGerald GA, Daley GQ, Orkin SH, Zon LI. Prostaglandin E₂ Regulates Vertebrate Hematopoietic Stem Cell Homeostasis, Nature, 447(7147):1007-11 (2007). (IF: 26.681; SJR: 6.203).

pdf

Price TS, Lucitt MB, Wu W, Austin DJ, Pizarro A, Yocum AK, Blair IA, FitzGerald GA, Grosser T.
EBP: Protein identification using multiple tandem mass spectrometry datasets. Mol Cell Proteomics. 6(3):527-36, (2007). (IF: 9.620; SJR: 2.170).

pdf

Fries S*, Grosser T* *[Co-Firstauthors], Lawson J, DeMarco S, FitzGerald GA. Marked Interindividual Variability in the Response to Selective Inhibitors of Cyclooxygenase-2., Gastroenterology  Jan;130(1):55-64 (2006). (IF: 12.457; SJR: 1.644).

pdf

Rudic RD, McNamara P, Reilly D, Grosser T, Curtis AM, Price T, Panda S, Hogenesch J, FitzGerald GA, Bioinformatic analysis of circadian gene oscillation in mouse aorta. Circulation;112(17):2716-24 (2005). (IF: 10.940; SJR: 1.993).

pdf

Pini B*, Grosser T* *[Co-Firstauthors], Lawson J, Price TS, Pack M, FitzGerald GA. Zebrafish prostaglandin E₂ synthases, Arteriosclerosis, Thrombosis, and Vascular Biology; 25(2):315-320 (2005). (IF: 7.053; SJR: 1.288).

pdf

Grosser T, Yusuff  S, Cheskis E, Pack M, FitzGerald GA. Developmental expression of functional cyclooxygenases in zebrafish. Proc Natl Acad Sci (USA) 99 (12): 8418-23 (2002). (IF: 10.700; SJR: 3.732).

pdf

Cheng Y, Austin S, Rocca B, Koller BH, Coffman, TM, Grosser T, Lawson JA, FitzGerald GA. Role of prostacyclin in the cardiovascular response to thromboxane A₂. Science 296 (5567): 417-604 (2002).
(IF: 26.682; SJR: 7.132).

pdf

Ibe W, Bartels W, Lindemann S, Grosser T, Buerke M, Boissel JP, Meyer J, Darius H. Involvement of PKC and NF-kappaB in nitric oxide induced apoptosis in human coronary artery smooth muscle cells. Cell Physiol Biochem 11(5):231-40 (2001). (IF: 2.853; SJR: 0.397).

Lindemann S, Sharafi M, Spiecker M, Buerke M, Fisch A, Grosser T, Veit K, Gierer C, Ibe W, Meyer J, Darius H. NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1 mRNA and surface expression. Thrombosis Research 97(3):113-23 (2000). (IF: 1.323; SJR: 0.248).

pdf

Zacharowski K, Schneidmuller D, Ibe W, Grosser T, Buerke M, Meyer J, Darius H. Effects of local delivery of trapidil on neointima formation in a rabbit angioplasty model. British Journal of Pharmacology 129(3):566-72 (2000). (IF: 3.689; SJR: 0.932).

pdf

Veit K, Boissel JP, Buerke M, Grosser T, Meyer J, Darius H. Highly efficient liposome-mediated gene transfer of inducible nitric oxide synthase in vivo and in vitro in vascular smooth muscle cells. Cardiovascular Research 43(3):808-22 (1999). (IF: 3.092; SJR: 0.155).

pdf

Zucker T-P, Boenisch D, Hasse A, Grosser T, Weber A-A, Schror K. Tolerance development to antimitogenic actions of prostacyclin but not to prostaglandin E₁ in coronary artery smooth muscle cells. Eur J Pharmacol 345, 213-220 (1997). (IF: 2.047).

pdf

Grosser T, Zucker T-P, Weber A-A, Schulte K, Sachinids A, Vetter H, Schror K Thromboxane A₂ induces cell signaling but requires platelet-derived growth factor to act as a mitogen. Eur J Pharmacol 319, 327-332 (1997). (IF: 2.047).

pdf

Braun M, Grosser T, Schror K. Bioactivation of nitroglycerin in vascular smooth muscle cells is different from that in non-vascular tissue. Eur J Pharmacol 276, 239-245 (1995).

pdf

Grosser T, Boenisch D, Zucker T-P, Schror K. Iloprost-induced inhibition of proliferation of coronary artery smooth muscle cells is abolished by homologous desensitization. Agents Actions 45, 85-91 (1995).

Zucker T-P, Grosser T, Morinelli T, Halushka PV, Sachinidis A, Vetter H, Schror K. Potentiation of PDGF-induced growth responses in coronary artery smooth muscle cells by thromboxane. Agents Actions 45, 53-58 (1995).